Global CRISPR Cas9 Market, Clinical Trials and Therapeutic Application Outlook 2024

  • No. of Pages: 200
  • Publish Date: October-2019
  • Category: Pharmaceutical and Healthcare
Electronic Access - Single User License
$2800
CD-ROM Mail Delivery
$3600
Hard Copy Mail Delivery
$4500
Electronic Access - Multi-User License
$5000

"Global CRISPR Cas9 Market, Clinical Trials and Therapeutic Application Outlook 2024"  Report Highlight:

 

  • Global CRISPR Cas9 Market Overview

  • Global CRISPR Cas9 Clinical Trials: More Than 40 Trials

  • Global CRISPR Cas9 Clinical Trials by Company and Indication

  • Global CRISPR Cas9 Market Regional Scenario

  • Global CRISPR Cas9 Therapy Application by Multiple Indications

  • Key Companies Profile Involved In Clinical Trials: 12 Companies

 

CRISPR technology is one of the most advanced technology falling under the category of gene editing. It stands out as a mature existing system that can be used to engineer the genes with the desired ones. CRISPR contains innovative capabilities making its potential benefits endless. Till now, the theoretical knowledge about CRISPR has gained much attention and now it’s the time for us to apply it for the practical use.

 

CRISPR is one such technology that has totally revolutionized the working process in the scientific field. It has been only few years since its discovery and CRISPR has started dominating the research labs all over the world. Inspite of being a newly discovered technology, CRISPR has come out with latest methodologies of treating diseases with genetic or lifestyle inherited diseases.

 

Making targeted changes to the genome of an individual which was a long-standing goal for the researchers, has now become a dream come like true situation. The development of CRISPR technology has helped the bio-medical researchers to put out any experiment in an efficient way. CRISPR is not the first tool to get discovered for performing gene editing but it has made its way all to the top of the list in gene editing technologies.

 

CRISPR technology comes with a lot of potential in it. It is the most advanced technology for treating deadly diseases that the mankind is suffering from. CRISPR is successful in showing positive results in curing diseases such as: Sickle cell anemia, cancer, hepatitis B and cholesterol. CRISPR is used for producing alterations in the somatic cell lines as well as the germline (reproductive cells). With this application of CRISPR, it is possible to correct the mutation residing inside the genome of a fetus.

 

Clinical trials about the CRISPR components help in achieving the efficacy of the technology. More than 30 CRISPR-Cas9 clinical trials are going on, with a participation of more than 1,000 patients. Among all the countries, US and China are the most active countries that are running the maximum number of trials. CRISPR has not only marked its presence in the pharma sector, it has also come across a long path in gaining respect in the agriculture field. There is constant innovation going on in the laboratories for attaining maximum benefits from the CRISPR components.

 

The increasing potential benefits received from CRISPR are creating an unimaginable effect on the market of CRISPR across the globe. The market of CRISPR is going through a giant progress, as the benefits from CRISPR are increasing day by day. The market of CRISPR has shown a tremendous jump over the last few years. Researchers are also exploring different ways of utilizing CRISPR in both diagnostic as well as therapeutic development.

 

The successful commercialization of such development is likely to drive the market’s revenue growth. The market of CRISPR is also driven by the increasing number of cancer cases, autoimmune diseases in the world. Inspite of the increasing cancer cases around the globe, other major factors driving the growth of CRISPR are the leading manufacturers of the pharmaceutical industry, technological advancements and the presence of skilled researchers. 

Need custom market research solution? We can help you with that too.